In male Siberian hamsters, administration of adult physiological levels of testosterone (T) and estrogen (E 2 ) to juveniles inhibited pubertal onset by distinct pathways. It is presently unclear if T and E 2 also exert an inhibitory effect on the reproductive function of sexually mature and sexually maturing hamsters. This study aims to determine if there is an age-dependent decline in the sensitivity of the hypothalamic-pituitary-gonadal (HPG) axis to these inhibitory steroids and if their actions remain distinct. Peripubertal and adult male Siberian hamsters were implanted with a silastic capsule containing T, E 2 , or cholesterol (Ch, control). Testosterone treatment significantly reduced testes mass and length and impaired spermatogenesis in both ages. In contrast, E 2 treatment reduced testes mass only in peripubertal, but not adult, animals. In fact, E 2 treatment significantly increased testes mass in adults without altering spermatogenesis. In addition, circulating E 2 is very high immediately prior to pubertal onset and declines thereafter. Our results showed the inhibitory effects of T persist into adulthood whereas those of E 2 subside as the animals become sexually mature. The decreased sensitivity of the HPG axis to the inhibitory effects of E 2 in adult animals and the high level of circulating E 2 immediately prior to pubertal onset suggest E 2 may play an important role in the regulation of puberty in this species.
INTRODUCTION
In mammals, the initiation of puberty is a complex event requiring the activation of the hypothalamo-pituitary-gonadal (HPG) axis by multiple neural and hormonal inputs. Reproductive capacity is further modulated by the specific inhibitory actions of androgenic and estrogenic steroid hormones. It has been shown that rats, ferrets, sheep, and monkeys become less sensitive to the inhibitory effects of testosterone (T) and estrogen (E 2 ) during the course of sexual maturation [1] [2] [3] [4] . However, the precise role of the observed decrease in steroid sensitivity during the pubertal transition is unknown. Previously, we have shown that chronic administration of adult physiologic doses of T and E 2 delayed puberty in the juvenile male Siberian hamster (Phodopus sungorus) [5] . The delay in gonadal development exerted by T is indefinite, lasting up to 10 mo (unpublished observations). In addition, we demonstrated that T and E 2 inhibited puberty by distinct pathways. For instance, T inhibited the release of FSH from the pituitary, whereas E 2 may have acted more upstream by inhibiting FSH synthesis [5] .
It is presently unclear why adult levels of T can delay pubertal onset indefinitely in juveniles since adult males are reproductively competent under the influence of the same levels of circulating T. One possibility is that a decrease in the sensitivity to inhibitory steroids never occurs in these hamsters during pubertal transition. This could explain why these animals failed to overcome the inhibitory effects of exogenous T and E 2 to reach puberty. In this case, other mechanisms are required to initiate puberty and support the continuing activity of the HPG axis despite the natural increase in circulating T [6] . A second possibility is that these animals, like other rodents studied, become less sensitive to inhibitory steroids as they approach puberty, allowing them to reproduce under high levels of circulating sex steroids. However, early exposure of prepubertal animals to adult levels of T and E 2 in our previous study may have suppressed this transition toward sexual maturation. Regardless of the mechanisms involved, information on how these animals respond to inhibitory steroids during and after pubertal transition is critical to the understanding of changes in the HPG axis as the animal becomes sexually mature.
The goal of this study is twofold. First, we examined the ability of T and E 2 to exert inhibitory effects on the HPG axis in peripubertal and adult Siberian hamsters. Our aim was to determine if sexual maturation in Siberian hamsters is accompanied by a decreased sensitivity to both steroids. Second, we investigated whether the actions of T and E 2 on the HPG axis remain distinct at different ages. Our results indicate that the Siberian hamster remains very sensitive to the inhibitory effects of T but not of E 2 after the onset of puberty. Further, the actions of T and E 2 remain distinct throughout pubertal onset and adulthood.
MATERIALS AND METHODS

Animals
Male Siberian hamsters were raised from birth under long-day photoperiod (16L:8D, lights-on at 0430 h) and weaned at 20 days of age. Animals were singly housed in shoebox cages and given water and rodent chow ad libitum. All experimental procedures are in accord with the animal protocols approved by the University of Colorado at Boulder Institutional Animal Care and Use Committee.
Hormone Treatments and Tissue Collection
Male Siberian hamsters at 35 days of age (peripubertal, n ϭ 24) or 140-145 days of age (adult, n ϭ 24) were subcutaneously implanted with a silastic capsule containing crystalline T, E 2 , or cholesterol (Ch, control) as described previously [5] . In brief, 1-mm-long silastic tubing was packed with undiluted T, E 2 , or Ch and sealed on each end with silicon glue. The capsules were allowed to equilibrate for at least 3 days in 0.9% saline until implanted. Animals were lightly anesthetized with halothane gas and the implant was inserted between the scapulae. An initial laparotomy was performed to ensure testes size was not significantly different among assigned groups before hormone implants. Retro-orbital blood samples were obtained for the measurement of circulating levels of FSH at 0, 15, and 30 days postimplant. Circulating T and E 2 were also measured for 30- day-postimplant plasma samples. All animals were killed by cervical dislocation at 30 days postimplant and their pituitaries and testes removed for histological analysis and measurements of mass (testes) and hormone levels (pituitaries). All animals were inspected for the presence of a silastic capsule containing packed hormone.
An additional group of 28 untreated animals were separated into six groups of 4-5 animals. Each group was bled at one of the six specific ages (20, 25, 30, 35 , 40, or 140 days of age) to obtain a normal plasma E 2 profile.
Radioimmunoassays
FSH RIA. Blood samples were collected into heparinized tubes, centrifuged at 3000 rpm for 8 min, and stored at Ϫ20ЊC until assayed for FSH by RIA. Detection of plasma and pituitary FSH by RIA was performed as described previously [5] . In brief, rFSH-I9, rFSH-RP2, and rFSH-S-11 from the NIH National Pituitary Program (obtained from Dr. A.F. Parlow) were used as the iodination stock, RIA standard, and antibody, respectively. The limit of detection was 1.0 ng/ml. Intra-assay and interassay coefficients of variation were 6.6 Ϯ 2.4% and 8.9 Ϯ 1.5%, respectively.
T and E 2 RIAs. Testosterone and E 2 RIA kits were purchased from Diagnostic Systems (Webster, TX). Plasma samples were assayed according to manufacturer's directions. Assay limits of detection were 80 pg/ml and 6.5 pg/ml for T and E 2 , respectively. Both RIAs are highly specific and cross-react minimally with other forms of steroid hormones.
Histology
Testes were immersion fixed in Bouin fixative overnight and then stored in 70% ethanol. Testes were dehydrated through a standard series of increased ethanol concentrations and were embedded in paraffin wax. Ten-micrometer sections were cut, mounted on poly-L-lysine coated slides, and stained with hematoxylin and eosin. For morphometric analysis, 6-8 fields per section from a total of 15 sections per animal were scored. A minimum of three animals per treatment group was measured. Sections were all from the center of the testis, and only tubules cut in a crosssection that appeared round were measured. General characteristics of cell types and appearance, seminiferous tubule diameter, and lumen diameter were recorded. Measurements were made using bright-field microscopy with a calibrated micrometer.
Statistical Analysis
Differences among groups were tested using one-way ANOVA followed by Tukey honestly significant difference post hoc analysis. For analysis of all hormone levels by RIA, animals with undetectable levels were assigned a value of 0.00 ng/ml and included in the mean calculation. Hence, some of the mean values are below the limits of assay detectability.
Differences were considered significant when P Ͻ 0.05. All data are presented as mean Ϯ SEM.
RESULTS
Testosterone and E 2 treatments differentially altered testicular growth in peripubertal and adult animals. In peripubertal animals, both T and E 2 significantly decreased testes mass after 30 days of hormone implant, although the inhibitory effect of T was more potent than that of E 2 ( Fig.  1) . In adults, while T remained inhibitory to testes mass, E 2 became stimulatory and significantly enhanced adult testes mass (Fig. 1) . Our initial laparotomy revealed no significant difference in the testicular length among treatment groups within the same age prior to hormone implants (data not shown).
Testosterone treatment markedly affected testes morphology and spermatogenesis in both peripubertal and adult animals. In both age groups, the lumen of T-treated animals was either completely closed or very small (Ͻ5 m; Figs. 2A, 3A, and 4A). Testosterone treatment also significantly reduced seminiferous tubule diameter in both peripubertal and adult animals compared with Ch-treated controls (Fig.  2B) . In T-treated peripubertal animals, the seminiferous tubules were tightly packed together with very little interstitial space (Fig. 3A) . Consequently, the Leydig cells appeared to be few, and many were shrunken or irregularly shaped, as seen in pyknotic cells, suggesting that T treatment may have compromised the health of these cells ( 3A). However, in T-treated adult animals, the interstitial space appeared normal and Leydig cells were more numerous, yet many Leydig cells still appeared pyknotic (Fig.  4A) . In both age groups, primary and secondary spermatocytes were present, but spermatids were scarce and mature sperm absent, suggesting spermatogenesis was adversely affected by T treatment (Figs. 3A and 4A) .
Consistent with our previous findings in prepubertal animals [5] , E 2 actions on testes morphology and spermatogenesis were distinct from T in both age groups studied. In peripubertal animals, E 2 treatment significantly reduced seminiferous tubule and lumen diameters compared with controls (Fig. 2) . In adult animals, however, E 2 treatment had no effect on seminiferous tubule or lumen diameters (Figs. 2 and 4B) . In both peripubertal and adult E 2 -treated animals, the interstitial space and Leydig cell populations appeared similar to Ch-treated controls (Fig. 3, B and C;  Fig. 4 , B and C). Treatment with E 2 affected spermatogenesis in peripubertal but not in adult animals. In peripubertal animals, there were numerous primary and secondary spermatocytes, but fewer spermatids were present and mature sperm absent (Fig. 3B) . On the other hand, E 2 treatment did not appear to affect spermatogenesis in the adults when compared with controls, as primary spermatocytes, secondary spermatocytes, spermatids, and mature sperm were present (Fig. 4B) .
Testosterone and E 2 had no effect on plasma FSH levels in peripubertal or adult animals ( Table 1) . Several animals in each treatment group had undetectable levels of plasma FSH; therefore, the calculated group mean is below the limit of detectability for the assay (1.0 ng/ml). The number of animals with detectable plasma FSH within the treatment group is indicated in Table 1 . Consistent with our previous finding in prepubertal animals [5] , E 2 treatment significantly reduced FSH concentration in the pituitary in both peripubertal and adult animals ( Table 1) . T-treated animals, however, were not different from control animals in either age group (Table 1) .
The dose of T administered during this study is sufficient to significantly elevate circulating T in peripubertal animals to levels similar to, but never exceeding, those in intact adult males (Table 1 ) [5] . However, E 2 implants did not result in significantly higher plasma E 2 compared with controls in either age group (Table 1) . Plasma E 2 profiles of animals during and after pubertal transition revealed circulating E 2 was highest immediately before pubertal onset (20 days of age; Fig. 5 ). This level was significantly higher than all other time points studied.
DISCUSSION
Two important findings regarding steroid hormone actions during the pubertal transition in the male Siberian hamster emerged from the present study. First, we observed a significant decline in the level of circulating E 2 and the ability of E 2 to halt gonadal growth as the animal becomes sexually mature. This dynamic decline of E 2 activity during the pubertal transition contrasts sharply with the static nature of the inhibitory effect of T, which persists well into adulthood with relatively little change. Second, throughout the course of sexual maturation, the actions of E 2 and T on the HPG axis remain distinct. These results implicate E 2 as one of the primary physiological regulators of the HPG axis prior to pubertal onset and suggest that T and E 2 may have dissociated physiological roles in the regulation of pubertal progression.
Our observation that circulating E 2 is high in prepubertal males and steadily declines thereafter (Fig. 5 ) raises the novel possibility that E 2 may play a physiological role in inhibiting the activity of the HPG axis prior to, but not after, the attainment of sexual maturity in male Siberian hamsters. This possibility is further supported by a potent inhibitory effect of E 2 on testicular development in peripubertal, but not adult, hamsters. This study, however, investigated the progression of puberty and not the mechanisms controlling pubertal onset. Future studies using estrogen agonists and antagonists are required to establish the specific role of estrogen in the initiation of pubertal onset in these hamsters. In other species studied, the role of estrogen in pubertal onset has not been clearly established. For example, a previous study reported active immunization against estrogen in prepubertal lambs failed to advance the onset of puberty [7] .
To the best of our knowledge, this is the first report of E 2 treatment increasing testes mass in adult animals. In fact, our data contradict a previous report that E 2 administration (Ͼ100 g kg Ϫ1 day Ϫ1 ) for 60 days to adult male rats significantly reduced testes mass, sperm motility, and serum FSH and LH levels [8] . Our results were unexpected, but recent findings suggest several possible mechanisms for the stimulatory action of E 2 on the testes. In one study, when prepubertal rats were given both E 2 and FSH, E 2 enhanced the stimulatory effect of FSH on spermatogenesis, resulting in a significant increase in the number of spermatogonia compared with rats given FSH alone [9] . In that study, however, mean testes mass was not different between the two groups, suggesting that an increase in total number of spermatogonia alone may not be sufficient for the observed increased testes mass in our study.
Another possible mechanism for E 2 -induced increase in testicular mass is that E 2 may disrupt the normal fluid balance in the testes, resulting in fluid accumulation and increased testes mass. Studies have shown that E 2 is an important regulator of fluid balance in the efferent ductules of the testes (see [10] for a review). For instance, in estrogen receptor alpha-null (␣ERKO) mice, the efferent ductules are severely dilated due to their inability to reabsorb testicular fluid [11] . As a consequence, fluid accumulates in the testes and results in dilated lumens and reduced germinal epithelium in the seminiferous tubules [12] . This effect begins in the caudal portion of the testes and propagates to other regions of the testes as the animal ages. Similarly, adult rats and mice given an antiestrogen, ICI182,780, also showed dilation and increased fluid retention in the efferent ductules [13, 14] . While mild testicular fluid accumulation is not always apparent by conventional histological observations, fluid that accounted for a 30% increase in the testicular mass (Fig. 1) should visibly distort testicular morphology. In fact, most cases of severe testicular fluid accumulation resulted in gross morphological alterations that are readily visible [12] [13] [14] . Our histologic analysis revealed no difference in the overall sizes of the lumen and seminiferous tubule diameters between E 2 -treated and control animals. Again, the influence of E 2 on testicular fluid balance, if any, may not be the sole contributor of increased testicular mass.
A third possible mechanism for E 2 -stimulated increase in testicular mass is that E 2 may stimulate FSH or LH secretion, resulting in excessive stimulation of Sertoli, Leydig, and germ cells in the testes [15, 16] . Our results failed to support a stimulatory effect of E 2 on circulating FSH (Table 1) , and the lack of a LH RIA sensitive enough to measure circulating LH in the Siberian hamster precluded our ability to assess E 2 effects on LH secretion.
At present, the precise mechanism responsible for E 2 stimulation of testicular mass is not known. However, it is clear that adult Siberian hamsters differ markedly from other rodent species investigated in their ability to respond to E 2 with increased gonadal growth. Unlike laboratory rats and mice, Siberian hamsters are a photoperiodic species that undergoes seasonal gonadal regression and spontaneous recrudescence. Whether or not this plastic nature of gonadal growth allows for the observed increased testes mass in response to E 2 treatment remains to be investigated. It should also be noted that, because the animals in this study were gonadally intact, unidentified gonadal factors might influence the progress of puberty and steroid responsiveness of the testes.
Testosterone or E 2 treatments in peripubertal animals did not significantly alter circulating FSH compared with controls (Table 1) . This lack of effect, however, could be partially attributed to the very low circulating FSH levels in control peripubertal Siberian hamsters, making any further drop in circulating FSH difficult to detect with the sensitivity of our existing RIA. In adult animals, we also did not find any significant difference in plasma FSH among treatment groups (Table 1) . Again, this lack of effect could be a consequence of the limited RIA sensitivity. Our previous study in prepubertal hamsters [5] reported circulating FSH levels that were several times higher than those in the older hamsters used in this study. This discrepancy is due to the presence of a prominent peak in circulating FSH during the early pubertal phase that drops off rapidly in late puberty [6] . Our previous study measured plasma FSH levels at the time of this pubertal FSH peak, whereas our current study measured FSH levels at the tail end the peak [5] . Thus, our current FSH levels are lower than our previous report. However, it is unclear why our FSH levels are several orders of magnitude lower than earlier reports [6, 17] on circulating FSH in Siberian hamsters at various stages of sexual maturation. The most likely explanation is the difference in standards, antibody, and iodination stock used in some earlier studies, as a more recent report showed circulating FSH levels consistent with our data using the same RIA reagents [18] .
In this study, treatment with E 2 significantly lowered total pituitary FSH concentration in both age groups (Table  1) . This is in agreement with our previous results in prepubertal animals [5] . The ability of E 2 to significantly decrease pituitary FSH in prepubertal, peripubertal, and adult hamsters but not testicular mass in the latter suggests that the efficacy of E 2 inhibitory action does not decline equally at all sites of the HPG axis as the animal becomes sexually mature. Clearly, adults are able to compensate for the deficiency in pituitary FSH and still secrete sufficient FSH to maintain spermatogenesis. Our results also showed T treatment, unlike E 2 , did not affect pituitary FSH concentration at either age, further demonstrating the distinct nature of T and E 2 actions (Table 1) .
In this study, circulating T and E 2 levels in hormoneimplanted animals were all within the physiological limit for this species (Table 1) . Surprisingly, T and E 2 implants did not significantly elevate plasma T and E 2 in adults (Table 1). This result was unexpected because we anticipated hormones coming from the capsules to add to endogenous hormones produced by the testes, elevating circulating T and E 2 levels above those of controls. It is possible that Leydig cell function and endogenous steroid hormone synthesis were compromised in the steroid-treated group, leaving the capsule as the primary source of gonadal steroid.
At present, the precise role of high E 2 levels in prepubertal male hamsters is unclear (Fig. 5) . A similar observation has been made previously only once in rats by Döh-ler and Wuttke [19] , who first reported high levels of E 2 in prepubertal male rats between Postnatal Days 9 and 19. It is possible that E 2 plays a preparatory role in the initiation of spermatogenesis at the time of pubertal onset. Recent studies in ␣ERKO mice have shown that an estrogen receptor-dependent process is required for normal spermatogenesis (see [20] for a review). Despite normal plasma gonadotropin and androgen levels, ␣ERKO mice are infertile because of the lack of functional mature sperm. E 2 has also been shown to be a germ cell survival factor in humans, reinforcing the idea that E 2 is required for male fertility [21] . Another possibility is that E 2 serves as a primary suppressor of the HPG axis until the time of puberty, after which the decline in circulating level and activity diminishes its role in HPG regulation (Fig. 5) . This idea parallels the gonadostat theory, which proposed a decrease in sensitivity to the inhibitory actions of gonadal steroid hormones as a mechanism for pubertal onset [1] . Although this theory has been refuted in several species (see [22] for a review), the decreased inhibitory actions of E 2 could still play a notable role in the pubertal initiation of male Siberian hamsters.
Taken together, our data implicate E 2 as a major regulator of the HPG axis in male Siberian hamsters. High circulating E 2 prior to pubertal onset as well as a decline in sensitivity to the inhibitory effects of E 2 after puberty strongly suggest the changing role of E 2 during pubertal progression. In addition, contrary to what has been observed in the rat [1] , an age-dependent decline in sensitivity to the inhibitory effects of T does not occur in the Siberian hamster. The ability of Siberian hamsters to respond persistently to the inhibitory effects of T at all ages contrasts sharply with their changing responsiveness to E 2 , further affirming the distinct roles of these two steroids in the regulation of the reproductive function in the male Siberian hamster.
